Skip to main content
. 2017 Oct 18;152(10):944–950. doi: 10.1001/jamasurg.2017.1716

Table 1. Clinical Characteristics of Patients by Fat-Grafting Status.

Variable Fat Graft Status Between Postoperative Years 1 and 2a P Value
Fat Grafted
(n = 165)
Non–Fat-Grafted
(n = 1883)
Age, mean (SD), y 47.5 (8.5) 49.5 (10.1) .01
BMI, mean (SD) 26.6 (5.1) 26.7 (5.6) .86
Race, No. (%)a
White 146 (89.0) 1649 (88.6) .91
African American 10 (6.1) 107 (5.7)
Other 8 (4.9) 105 (5.6)
Ethnicity, No. (%)a
Hispanic/Latino 6 (3.7) 110 (6.0) .24
Non-Hispanic/Latino 156 (96.3) 1731 (94.0)
Smoking history, No. (%)a
Nonsmoker 107 (64.8) 1211 (65.0) .64
Previous smoker 56 (33.9) 610 (32.7)
Current smoker 2 (1.2) 43 (2.3)
Procedure type, No. (%)
Implant 87 (52.7) 1139 (60.5) .04
Autologous 72 (43.6) 714 (37.9)
Mixed 6 (3.6) 30 (1.6)
Laterality, No. (%)
Unilateral 65 (39.4) 824 (43.8) .28
Bilateral 100 (60.6) 1059 (56.2)
Indication for mastectomy, No. (%)
Therapeutic 150 (90.9) 1682 (89.3) .53
Prophylactic 15 (9.1) 201 (10.7)
Timing of reconstruction, No. (%)
Immediate 148 (89.7) 1690 (89.8) .98
Delayed 13 (7.9) 143 (7.6)
Mixed 4 (2.4) 50 (2.7)
Radiotherapy, No. (%)
Before reconstruction 22 (13.3) 289 (15.3) .006
During/after reconstruction 38 (23.0) 262 (13.9)
None 105 (63.6) 1332 (70.7)
Fat grafting during postoperative year 1, No. (%)
Yes 50 (30.3) 355 (18.9) <.001
No 115 (69.7) 1528 (81.1)
Other revision procedure done between postoperative years 1 and 2, No. (%)
Yes 123 (74.5) 310 (16.5) <.001
No 42 (25.5) 1573 (83.5)
Cancer recurrence between postoperative years 1 and 2, No. (%)
Recurred 3 (1.8) 38 (2.0) .86
Did not recur 162 (98.2) 1845 (98.0)
Complication during postoperative year 1, No. (%)
Yes 54 (32.7) 525 (27.9) .19
No 111 (67.3) 1358 (72.1)
Complication between postoperative years 1 and 2, No. (%)
Yes 11 (6.7) 48 (2.5) .002
No 154 (93.3) 1835 (97.5)

Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

a

Some data missing.